Zura Bio Ltd. (ZURA)
1.405
+0.16
(+13.31%)
USD |
NASDAQ |
Nov 10, 16:00
1.39
-0.02
(-1.07%)
After-Hours: 20:00
Zura Bio Net Income (Quarterly) : -25.82M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -25.82M |
| June 30, 2026 | -26.30M |
| March 31, 2026 | -24.22M |
| December 31, 2025 | -17.18M |
| September 30, 2025 | -18.04M |
| June 30, 2025 | -15.99M |
| March 31, 2025 | -17.44M |
| December 31, 2024 | -13.62M |
| September 30, 2024 | -20.70M |
| June 30, 2024 | -10.33M |
| March 31, 2024 | -7.747M |
| December 31, 2023 | -8.473M |
| Date | Value |
|---|---|
| September 30, 2023 | -8.27M |
| June 30, 2023 | -34.02M |
| March 31, 2023 | -9.795M |
| December 31, 2022 | 13.40M |
| September 30, 2022 | -1.102M |
| June 30, 2022 | -0.925M |
| March 31, 2022 | -7.819M |
| December 31, 2021 | 0.8176M |
| September 30, 2021 | 5.787M |
| June 30, 2021 | -0.0191M |
| March 31, 2021 | -0.033M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0858M |
| Brainstorm Cell Therapeutics, Inc. | -3.855M |
| Summit Therapeutics, Inc. | -208.38M |
| Kezar Life Sciences, Inc. | -5.756M |
| Protara Therapeutics, Inc. | -21.69M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 25.82M |
| EPS Diluted (Quarterly) | -0.2022 |
| Enterprise Value | -68.23M |
| Earnings Yield | -88.84% |
| Normalized Earnings Yield | -88.84 |